Rezultati - Karthikeyan Murugesan
- Showing 1 - 15 results of 15
-
1
-
2
-
3
-
4
-
5
Targeting Notch signalling pathway of cancer stem cells od Venkatesh, Vandana, Nataraj, Raghu, Thangaraj, Gopenath S., Karthikeyan, Murugesan, Gnanasekaran, Ashok, Kaginelli, Shanmukhappa B., Kuppanna, Gobianand, Kallappa, Chandrashekrappa Gowdru, Basalingappa, Kanthesh M.
Izdano 2018Text -
6
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers od Mark Yarchoan, Lee A. Albacker, Alexander C. Hopkins, Meagan Montesion, Karthikeyan Murugesan, Teena Vithayathil, Neeha Zaidi, Nilofer S. Azad, Daniel A. Laheru, Garrett M. Frampton, Elizabeth M. Jaffee
Izdano 2019Artigo -
7
Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases od Richard S.P. Huang, Lukas Harries, Brennan Decker, Matthew Hiemenz, Karthikeyan Murugesan, James Creeden, Khaled A. Tolba, Laura P. Stabile, Shakti Ramkissoon, Timothy F. Burns, Jeffrey S. Ross
Izdano 2022Artigo -
8
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns od Mason A. Israel, Natalie Danziger, Kimberly McGregor, Karthikeyan Murugesan, Ole Gjoerup, Ethan S. Sokol, Hanna Tukachinsky, Razelle Kurzrock, Shumei Kato, Jason K. Sicklick, Halla Nimeiri, Geoffrey R. Oxnard, Jeffrey S. Ross
Izdano 2021Artigo -
9
<i>KRAS</i> Allelic Variants in Biliary Tract Cancers od Gordon Taylor Moffat, Zishuo Ian Hu, Funda Meric‐Bernstam, Elisabeth Kong, Dean Pavlick, Jeffrey S. Ross, Karthikeyan Murugesan, Lawrence N. Kwong, Anaemy Danner De Armas, Anil Korkut, Milind Javle, Jennifer J. Knox
Izdano 2024Artigo -
10
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations od Karthikeyan Murugesan, Andrea Necchi, Timothy C. Burn, Ole Gjoerup, R. Greenstein, Melanie A. Krook, Jorge-Antonio Lopez, Meagan Montesion, Halla Nimeiri, A.R. Parikh, Sameek Roychowdhury, S. Schwemmers, Ian M. Silverman, Arndt Vogel
Izdano 2022Artigo -
11
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis od Richard S.P. Huang, David P. Carbone, Gerald Li, Alexa B. Schrock, Ryon P. Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S. Ross, Khaled A. Tolba, Jacob Sands, Geoffrey R. Oxnard, David R. Spigel
Izdano 2023Artigo -
12
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer od Smruthy Sivakumar, Dexter X. Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean C. Pavlick, Ole Gjoerup, Jeffrey S. Ross, Robert J. Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M. Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M. Venstrom, Geoffrey R. Oxnard, Priti S. Hegde, Ethan Sokol
Izdano 2022Artigo -
13
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response od Meagan Montesion, Karthikeyan Murugesan, Dexter X. Jin, Radwa Sharaf, Nora Sánchez, Ameet Guria, Max Minker, Gerald Li, Virginia Fisher, Ethan S. Sokol, Dean C. Pavlick, Jay A. Moore, Alan Braly, Gaurav Singal, David Fabrizio, Leah A. Comment, Naiyer A. Rizvi, Brian M. Alexander, Garrett M. Frampton, Priti S. Hegde, Lee A. Albacker
Izdano 2020Artigo -
14
Covalent ERα Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer od Craig Furman, Xiaoling Puyang, Zhaojie Zhang, Zhenhua J. Wu, Deepti Banka, Kiran Aithal, Lee A. Albacker, Ming‐Hong Hao, Sean Irwin, Amy Kim, Meagan Montesion, Alyssa Moriarty, Karthikeyan Murugesan, Tuong-Vi Nguyen, Victoria Rimkunas, Tarek Sahmoud, Michael J. Wick, Shihua Yao, Xun Zhang, Hao Zeng, Frédéric H. Vaillancourt, David M. Bolduc, Nicholas Larsen, Guo Zhu Zheng, Sudeep Prajapati, Ping Zhu, Manav Korpal
Izdano 2022Artigo -
15
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer od Marcelo V. Negrão, Ferdinandos Skoulidis, Meagan Montesion, Katja Schulze, Ilze Bāra, Vincent K. Shen, Hao Xu, Sylvia Hu, Dawen Sui, Yasir Y. Elamin, Xiuning Le, Michael E. Goldberg, Karthikeyan Murugesan, Chang‐Jiun Wu, Jianhua Zhang, David S Barreto, Jacqulyne Robichaux, Alexandre Reuben, Tina Cascone, Carl M. Gay, K. G. Mitchell, Lingzhi Hong, Waree Rinsurongkawong, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, Anne S. Tsao, Vassiliki A. Papadimitrakopoulou, Don L. Gibbons, Bonnie S. Glisson, Gaurav Singal, Vincent A. Miller, Brian M. Alexander, Garrett M. Frampton, Lee A. Albacker, David S. Shames, Jianjun Zhang, John V. Heymach
Izdano 2021Artigo
Iskalna orodja:
Sorodne teme
Medicine
Biology
Cancer
Cancer research
Internal medicine
Genetics
Gene
Oncology
Immunotherapy
Lung cancer
Mutation
Pathology
Bioinformatics
Biomarker
Colorectal cancer
Immune checkpoint
Immunology
KRAS
Adenocarcinoma
Allele
Biopsy
Breast cancer
CDKN2A
CDKN2B
Cohort
IDH1
Immunohistochemistry
Intrahepatic Cholangiocarcinoma
PD-L1
Receptor